Susquehanna International Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
141,000
+14,319
| +11% | +$145K | ﹤0.01% | 2746 |
|
|
2025
Q1 | $707K | Buy |
126,681
+95,619
| +308% | +$534K | ﹤0.01% | 3855 |
|
|
2024
Q4 | $251K | Buy |
31,062
+5,527
| +22% | +$44.6K | ﹤0.01% | 4978 |
|
|
2024
Q3 | $262K | Sell |
25,535
-8,510
| -25% | -$87.2K | ﹤0.01% | 4475 |
|
|
2024
Q2 | $241K | Buy |
+34,045
| New | +$241K | ﹤0.01% | 4499 |
|
|
2024
Q1 | – | Sell |
-54,389
| Closed | -$500K | – | 6306 |
|
|
2023
Q4 | $500K | Buy |
54,389
+44,300
| +439% | +$408K | ﹤0.01% | 3865 |
|
|
2023
Q3 | $61K | Sell |
10,089
-887
| -8% | -$5.37K | ﹤0.01% | 5063 |
|
|
2023
Q2 | $85.2K | Sell |
10,976
-227,462
| -95% | -$1.77M | ﹤0.01% | 5066 |
|
|
2023
Q1 | $1.36M | Buy |
238,438
+139,151
| +140% | +$793K | ﹤0.01% | 2455 |
|
|
2022
Q4 | $585K | Buy |
99,287
+79,310
| +397% | +$467K | ﹤0.01% | 2985 |
|
|
2022
Q3 | $64K | Sell |
19,977
-60,628
| -75% | -$194K | ﹤0.01% | 5430 |
|
|
2022
Q2 | $361K | Buy |
80,605
+48,533
| +151% | +$217K | ﹤0.01% | 3751 |
|
|
2022
Q1 | $171K | Buy |
32,072
+6,090
| +23% | +$32.5K | ﹤0.01% | 4918 |
|
|
2021
Q4 | $382K | Buy |
25,982
+8,916
| +52% | +$131K | ﹤0.01% | 4176 |
|
|
2021
Q3 | $357K | Sell |
17,066
-4,978
| -23% | -$104K | ﹤0.01% | 4104 |
|
|
2021
Q2 | $390K | Sell |
22,044
-21,312
| -49% | -$377K | ﹤0.01% | 4184 |
|
|
2021
Q1 | $1.06M | Buy |
+43,356
| New | +$1.06M | ﹤0.01% | 2912 |
|